Emcure Pharmaceutical To Launch Oral Covid-19 Drug In India.
[email protected]14 Jan, 2022News
New Delhi, Dec 31 (IANS) Homegrown Emcure Pharmaceuticals Ltd on Friday announced that it has received Emergency Use Authorisation (EUA) approval for the launch of Molnupiravir, an investigational oral anti-viral drug, for the treatment of mild Covid-19. The pharmaceutical company, which has received approval from the Drug Controller General of India, said that it plans to launch Molnupiravir under the brand name Lizuvira in the Indian market.
Related Bookmarks
- The Ultimate Guide To Status Epilepticus
- Jens Erik Gould | StoryTracker
- Most trending NFT talks in 2021
- Pongal Festival 2022: Is It Right to Worship Surya Dev on Pongal Festival?
- Bgauss Bikes in India in 2022
- Best Natural Weight Less Body Wash
- Why Choose Arch City For Buying Or Leasing Semi-Trailers For Storage?
- Types of Flooring Options to Consider
- Projector with WiFi
- Best Heated Clothing to Keep You Warm All Winter Long
Recent Profiles
Dr Cp Gupta
Reddy Anna Id
88aa Nhà Cái
Mahaveer Constructions
Aostin
Terrapin Dispensaries
Lelioni Lucio
Smeg Appliances
Bespoke Plastic Surgery
Sc88